What a Certificate of Analysis Documents — and Why Characterization Comes First

What a COA is

A **Certificate of Analysis (COA)** is a batch document that records identity and quality test results for a specific lot. Typical elements include:

- Product / substance name as labeled

- Lot or batch number

- Test methods (for example, HPLC and mass spectrometry where used)

- Results and acceptance criteria as reported by the testing lab

- Dates and laboratory identification

For research buyers, the COA is how you connect an inventory item to measured data.

What a COA is not

- It is not FDA drug approval

- It is not proof that a market name is used consistently across the industry

- It is not a 503A Category 1 listing

- It is not a clinical outcome claim

FDA’s bulk-substance reviews ask a broader characterization question: can the agency define the substance being nominated across the materials bearing that name? A single lot COA helps a lab; it does not automatically answer FDA’s list-wide characterization factor.

Characterization → documentation → reproducibility

A practical quality chain looks like:

1. **Define** the substance (structure / sequence / salt form)

2. **Test** the lot with suitable methods

3. **Document** results on a COA tied to that lot

4. **Record** which lot entered which experiment

Skip step 1 and the paperwork in steps 2–4 becomes theater.

How this connects to regulatory news

When advisory briefing documents criticize weak characterization or inconsistent naming, they are pointing at failures of identity — the same failure mode COAs are meant to reduce at lot level. Reading those critiques as “quality system lessons” is more useful than reading them as shopping advice.

At USX Peptides, Certificates of Analysis are available for reviewed batches and can be requested through our website for research documentation needs.

*For research use only. Not for human or animal consumption.*